Meeting Another Cancer Survior ("If Winter Comes" No. 27)

All in all a great day, AJ has been going a lot today - he can feel some Neulasta soreness. Last time it was the inside of his thighs, now its the sides of his abdomen. He is tired tonight which would be expected from being up as much as he has today. Still he is NOT sweating anything at night.

I had another interesting conversation with another Swedish woman - Marie. She got diagnosed with stage lV breast cancer 10 years ago, it went away and came back 2 years later. According to statistics she should have been dead 5 years ago, she said. But she is still here, very much alive and kicking! She is receiving Chemo every two weeks and will do so for the rest of her life. That is what they do for stage lV breast cancer.

She said that she just learned to live with it and that it gets easier. Now, this is completely different than AJ's diagnoses and I don't compare illness or treatment. Its just nice to talk to people who have cancer and see how they experience theirs and little tips and stuff. Marie said she gets tired afterwards and sleeps for a few hours after her treatment. Then after a few days it can go away or not.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap